Sungen Biomedical is based in Beijing, China. It has raised $40M in total funding. Latest round: Series A.
Sungen Biomedical funding overview
Sungen Biomedical is based in Beijing, China. Sungen Biomedical has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A. Investors on record include Beijing Hotgen Biotech Co., Ltd., Qingdao Chuangjing Private Equity Fund Management Co., Ltd., Tianjin Hidea Venture Capital Management Co., Ltd., Green Pine Capital Partners Co., Ltd., Fortune Venture Capital Co., Ltd.. 5 distinct backers are named across the disclosed rounds.
Sungen Biomedical at a glance
Total raised
$40M
Latest round
Series A
Headquarters
Beijing, China
Notable investors
Beijing Hotgen Biotech Co., Ltd., Qingdao Chuangjing Private Equity Fund Management Co., Ltd., Tianjin Hidea Venture Capital Management Co., Ltd., Green Pine Capital Partners Co., Ltd., Fortune Venture Capital Co., Ltd.
Frequently asked about Sungen Biomedical funding
How much has Sungen Biomedical raised?
Sungen Biomedical has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Sungen Biomedical?
Beijing Hotgen Biotech Co., Ltd., Qingdao Chuangjing Private Equity Fund Management Co., Ltd., Tianjin Hidea Venture Capital Management Co., Ltd., Green Pine Capital Partners Co., Ltd., Fortune Venture Capital Co., Ltd. are named among the investors backing Sungen Biomedical.
What was the latest Sungen Biomedical funding round?
The most recent disclosed round is a Series A.
Where is Sungen Biomedical based?
Sungen Biomedical is based in Beijing, China.
We update the Sungen Biomedical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Beijing and their backers are listed below.
